Table 2.
Items | PFS (Univariate Analysis) | OS (Univariate Analysis) | ||
---|---|---|---|---|
HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
Age > 75 Years | 0.81 (0.34–1.91) | 0.63 | 1.45 (0.55–3.80) | 0.45 |
Male Gender | 1.47 (0.66–3.26) | 0.35 | 2.39 (0.80–7.17) | 0.12 |
Smoker | 1.508 (0.63–3.59) | 0.35 | 2.50 (0.73–8.58) | 0.14 |
ECOG-PS ≥ 2 | 2.21 (1.00–4.83) | 0.048 | 4.23 (1.65–10.89) | 0.0028 |
Squamous Histology | 1.08 (0.47–2.48) | 0.86 | 0.67 (0.24–1.83) | 0.43 |
EGFR Mutations Positive | 0.83 (0.28–2.43) | 0.73 | 1.17 (0.34–4.02) | 0.80 |
BMI > 20 | 0.47 (0.22–0.99) | 0.047 | 0.42 (0.17–1.02) | 0.056 |
BMI > 25 | 0.54 (0.19–1.59) | 0.27 | 0.92 (0.26–3.25) | 0.90 |
Corticosteroids Administration | 1.3 (0.49–3.52) | 0.58 | 0.66 (0.19–2.27) | 0.51 |
Alb > 3.5 g/dL | 0.53 (0.25–1.11) | 0.092 | 0.37 (0.15–0.90) | 0.028 |
CRP > 1.0 mg/dL | 1.44 (0.68–3.04) | 0.34 | 2.92 (1.10–7.76) | 0.032 |
LDH > 245 U/L | 1.41 (0.67–2.99) | 0.37 | 2.16 (0.89–5.24) | 0.090 |
NLR > 5.0 | 2.22 (1.02–4.84) | 0.045 | 1.98 (0.79–4.92) | 0.14 |
LMR > 1.7 | 0.44 (0.21–0.93) | 0.032 | 0.51 (0.21–1.23) | 0.14 |
PLR > 262 | 2.23 (0.99–5.03) | 0.054 | 2.80 (1.02–7.67) | 0.045 |
Liver Metastasis | 1.79 (0.61–5.28) | 0.29 | 1.95 (0.55–6.886) | 0.30 |
Brain Metastasis | 1.17 (0.47–2.91) | 0.73 | 0.58 (0.17–2.00) | 0.39 |
PD-L1 TPS 1–49% | 0.32 (0.096–1.05) | 0.059 | 0.55 (0.16–1.89) | 0.34 |
PD-L1 TPS > 50% | 0.35 (0.12–1.05) | 0.061 | 0.42 (0.12–1.49) | 0.18 |
Lines between First and Second ICIs > 2 | 1.26 (0.55–2.87) | 0.58 | 1.54 (0.59–4.04) | 0.38 |
PFS of First ICI >120 d | 1.06 (0.50–2.23) | 0.89 | 1.30 (0.55–3.08) | 0.54 |
Duration from the End of the First ICI to the Second ICI >157 d | 0.97 (0.47–2.02) | 0.94 | 0.77 (0.32–1.84) | 0.55 |
Partial Response with First ICIs | 0.58 (0.26–1.33) | 0.20 | 0.99 (0.40–2.48) | 0.98 |